RESULTS FOR : 'Regenerative Medicine'
Showing 1 to 3 of 3 results |    
Keyword Search
Show#
Show#
Results Category/Section
The California Institute for Regenerative Medicines Human iPSC Initiative.

Large-scale generation of patient-derived induced pluripotent stem cells to accelerate the understanding of disease biology and drug discovery. In 2012, the California Institute for Regenerative Medicine (CIRM) announced its Human iPSC Initiative, an ambitious effort to generate induced pluripotent stem cell (iPSC) lines from 3,000 donors.

REGENERATIVE MEDICINE promising answers in the face of an ageing population

As the population ages, the scientific and medical communities are working to solve the challenges this changing demographic will place on society. Companies involved in the promising field of regenerative medicine are now on the cutting edge as it strives to promote longevity without disability.

Regenerative Medicines: a paradigm shift in healthcare.

The regenerative medicine market offers phenomenal opportunities for growth in the next few decades. However, there are still major issues to be addressed to enable this nascent industry to truly flourish, especially with regard to investment and the attitudes of regulatory agencies and reimbursement bodies in an area which is relatively new to them.